bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
Given the dependence of modern medicine on antimicrobial drugs, and the inevitability of evolution, why is bringing a new antibiotic to market so difficult, and why are so many companies leaving the industry or going bankrupt?
Significant action from national and international leadership is needed to encourage and require antimicrobial stewardship programs in healthcare organizations.
Our 2019 toolkit provides resources for the public to learn about antimicrobial resistance, as well as resources for healthcare, scientific, and administrative professionals.
Fundamentally, doctors are blind without diagnostic tools. “It’s like looking for someone in a cave without any light,” says Dr. Mark Miller, Chief Medical Officer at bioMérieux. “You have no idea where you are.”
Patients at the greatest risk for secondary infections, particularly infections...
With the COVID-19 pandemic having reached over 170 countries, and...